Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus

Scandinavian Journal of Immunology

Volumn 65, Issue 4, 2007, Pages 320-328

  Zhang, Y L ^a   Guo, Y J ^a   Wang, K Y ^a   Lu, K ^a   Li, K ^a   Zhu, Y ^a   Sun, S H ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FOOT AND MOUTH DISEASE VACCINE; FREUND ADJUVANT; GAMMA INTERFERON; GST BTB PROTEIN; HEPATITIS B CORE ANTIGEN; INTERLEUKIN 4; PHBC1 BT PROTEIN; PHBC1 BTB PROTEIN; PHBC2 BT PROTEIN; PHBC2 BTB PROTEIN; PHBC3 BT PROTEIN; PHBC3 BTB PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTRON MICROSCOPY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENE DELETION; HEPATITIS B VIRUS; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; VIRUS LIKE AGENT;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; HEPATITIS B CORE ANTIGENS; IMMUNOBLOTTING; MICE; PHAGOCYTOSIS; PLASMIDS; RECOMBINANT FUSION PROTEINS; VACCINES, SYNTHETIC; VIRAL VACCINES; VIRION;

EID: 33947609904     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.01900.x     Document Type: Article

References (34)

1. Birnbaum F, Nassal M. Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol 1990;64:3319-30.
2. Newnan M, Suk FM, Cajimat M, Chua PK, Shih C. Stability and morphology comparisons of self-assembled virus-like particles from wild-type and mutant human hepatitis B virus capsid proteins. J Virol 2003;77:12950-60.
3. Watts NR, Conway JF, Cheng N, Stahl SJ, Belnap DM, Steven AC. The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface. Embo J 2002;21:876-84.
4. Hatton T, Zhou S, Standring DN. RNA- and DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication. J Virol 1992;66:5232-41.
5. Nassal M. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 1992;66:4107-16.
6. Newton SE, Clarke BE, Appleyard G, Francis MJ, Carroll AR, Rowlands DJ. New approaches to FMDV antigen presentation using vaccinia virus. In: Chanock RM, Lerner RA, Brown F, Ginsberg H, eds. Vaccines 87. Modern Approaches to New Vaccines: Prevention of AIDS and other Viral, Bacterial and Parasitic Diseases. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1987:12-21.
7. Pumpens P, Grens E. HBV core particles as a carrier for B cell/T cell epitopes. Intervirology 2001;44:98-114.
8. Ulrich R, Nassal M, Meisel H, Kruger DH. Core particles of hepatitis B virus as carrier for foreign epitopes. Adv Virus Res 1998;50:141-82.
9. Schodel F, Moriarty AM, Peterson DL, Zheng JA, Hughes JL, Will H. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J Virol 1992;66:106-14.
10. Kratz PA, Bottcher B, Nassal M. Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc Natl Acad Sci USA 1999;96:1915-20.
11. Schodel F, Weimer T, Will H, Milich D. Recombinant HBV core particles carrying immunodominant B-cell epitopes of the HBV preS2-region. In: Brown F, Chanock RM, Ginsberg HS, Lerner RA, eds. Vaccines 90. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1990:193-8.
12. Schodel F, Will H, Milich DR. Hybrid hepatitis-B virus core/pre-S particles expressed in live attenuated Salmonellae for oral immunization. In: Brown F, Chanock RM, Ginsberg HS, Lerner RA, eds. Vaccines 91. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1991:319-25.
13. von Brunn A, Reichhuber C, Brand M, Be chowsky B, Gurtler L, Eberle J. The principal neutralizing determinant (V3) of HIV-1 induces HIV-1-neutralizing antibodies upon expression on HBcAg particles. In: Ginsberg HS, Brown F, Chanock RM, Lerner RA, eds. Vaccines 93. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1993:159-65.
14. von Brunn A, Brand M, Reichhuber C, Morys-Wortmann C, Deinhardt F, Schodel F. Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles. Vaccine 1993;11:817-24.
15. Borisova G, Borschukova O, Skrastina D, Mezule G, Dislers A, Petrovskis I. Display vectors. I. Hepatitis B core particle as a display moiety. Proc Latv Acad Sci 1997;51:1-7.
16. Borschukova O, Skrastina D, Dislers A, Petrovskis I, Ose V, Zamurujeva I. Modified hepatitis B core particles as possible vaccine carriers. In: Brown F, Burton D, Doherty P, Mekalanos J, Norrby E, eds. Vaccines 97. Cold Spring Harbor: Cold Springer Harbor Laboratory Press, 1997:33-7.
17. Borisova G, Borschukova O, Skrastina D, Dislers A, Ose V, Pumpens P. Behavior of a short preS1 epitope on the surface of hepatitis B core particles. Biol Chem 1999;380:315-24.
18. Sobrino F, Domingo E. Foot-and-mouth disease in Europe. FMD is economically the most important disease of farm animals. Its re-emergence in Europe is likely to have consequences that go beyond severe alterations of livestock production and trade. EMBO Rep 2001;2:459-61.
19. Sobrino F, Domingo E. Foot-and-mouth disease. In: Current Perspectives. Norfolk, UK: Horizon Bioscience, 2004.
20. Pereira HG. Foot-and-mouth disease. In: Gibbs EPJ, ed. Virus Disease of Food Animals. London: Academic Press Inc., 1981:333-63.
21. Bachrach HL. Foot-and-mouth disease virus, properties, molecular biology and immunogenicity. In: Romberger JA, ed. Beltsville Symposia in Agricultural Research. Osmun, Montclair, NJ: Allanheld, 1977:3-32.
22. Belsham GJ, Martnez-Salas E. Genome organization, translation and replication of foot-and-mouth disease virus. In: Sobrino F, Domingo E, eds. Foot-and-Mouth Disease. Current Perspectives. Norfolk, UK: Horizon Bioscience, 2004.
23. Crowther JR, Farias S, Carpenter WC, Samuel AR. Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J Gen Virol 1993;74:1547-53.
24. Kitson JDA, McCahon D, Belsham GJ. Sequence analysis of monoclonal antibody resistant mutants of type O foot-and-mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 1990;179:26-34.
25. Bittle JL, Houghen RA, Alexander H et al. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 1983;298:30-3.
26. Blanco E, Garcia-Briones M, Sanz-Parra A et al. Identification of T-cell epitopes in nonstructural proteins of Foot-and-mouth disease virus. J Virol 2001;75:3164-74.
27. Blanco E, McCullough K, Summerfield A et al. Interspecies major histocompatibility complex-restricted. The cell epitope on foot-andmouth disease virus capsid protein VP4. J Virol 2000;74:4902-7.
28. van Lierop MJ, Wagenaar JP, van Noort JM, Hensen EJ. Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. J Virol 1995;69:4511-4.
29. Perez Filgueira M, Wigdorovitz A, Romera A, Zamorano P, Borca MV, Sadir AM. Detection and characterization of functional T-cell epitopes on the structural proteins VP2, VP3, and VP4 of foot and mouth disease virus O1 campos. Virology 2000;271:234-9.
30. Hoover DM, Lubkowski J. DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. Nucleic Acids Res 2002;30:e43.
31. Shire SJ, Bock L, Ogez J, Builder S, Kleid D, Moore DM. Purification and immunogenicity of fusion VP1 protein of foot and mouth disease virus. Biochemistry 1984;23:6474-80.
32. Capozzo AV, Periolo OH, Robiolo B, Seki C, LaTorre JL, Grigera PR. Total and isotype humoral responses in cattle vaccinated with foot-and-mouth disease virus (FMDV) immunogen produced either in bovine tongue tissue or in BHK-21 cell suspension cultures. Vaccine 1997;15:624-30.
33. Zhang HY, Sun SH, Guo YJ et al. Immune response in mice inoculated with plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus. Vaccine 2003;21:4704-7.
34. Francis MJ, Hastings GZ, Bronw AL et al. Immunological properties of hepatitis B core antigen fusion proteins. Proc Natl Acad Sci USA 1990;87:2545-9.